SNA-28455-19898
3 vaccinations
0 coded responses
20 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 631 / MO
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-03
Dose 1 — Pfizer-BioNTech
-
2021-02-24
Registered in v-safe
-
2021-02-24
Dose 2 — Pfizer-BioNTech
- 2021-02-24
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, NauseaAdult check-in
-
2021-02-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-05
- 2021-03-12
- 2021-03-17
- 2021-03-27
- 2021-04-01
- 2021-04-07
- 2021-05-26
- 2021-08-27
-
2022-01-19
Dose 3 — Pfizer-BioNTech
-
2022-01-25
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Itching · Muscle or body achesAdult check-in
- 2022-01-26
- 2022-02-04
- 2022-03-05
- 2022-04-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-03 | Pfizer-BioNTech | |
| 2 | 2021-02-24 | Pfizer-BioNTech | |
| 3 | 2022-01-19 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.